APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis C Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hepatitis C Drug Market Analysis and Forecast 2026-2032

Report ID 173997960220 December 2025197 pages

Choose your research edition.

Industry ResearchHepatitis C Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis C Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Hepatitis C Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis C Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis C Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Hepatitis C Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hepatitis C Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hepatitis C Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hepatitis C Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hepatitis C Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hepatitis C Drug include Johnson & Johnson, Merck, AbbVie, Kenilworth, Gilead and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hepatitis C Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hepatitis C Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Hepatitis C Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hepatitis C Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hepatitis C Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hepatitis C Drug sales, projected growth trends, production technology, application and end-user industry.

Hepatitis C Drug Segment by Company

Johnson & Johnson

Merck

AbbVie

Kenilworth

Gilead

Bristol-Myers Squibb

Hepatitis C Drug Segment by Type

Rx

OTC

Hepatitis C Drug Segment by Application

Hospital

Clinic

Other

Hepatitis C Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis C Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis C Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis C Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hepatitis C Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hepatitis C Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis C Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hepatitis C Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rx Major Manufacturers Table 3. OTC Major Manufacturers Table 4. Global Hepatitis C Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Hepatitis C Drug Industry Trends Table 9. Hepatitis C Drug Industry Drivers Table 10. Hepatitis C Drug Industry Opportunities and Challenges Table 11. Hepatitis C Drug Industry Restraints Table 12. Global Hepatitis C Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Hepatitis C Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Hepatitis C Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Hepatitis C Drug Revenue Market Share by Region (2021-2026) Table 16. Global Hepatitis C Drug Revenue Market Share by Region (2027-2032) Table 17. Global Hepatitis C Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Hepatitis C Drug Sales by Region (2021-2026) & (K Units) Table 19. Global Hepatitis C Drug Sales by Region (2027-2032) & (K Units) Table 20. Global Hepatitis C Drug Sales Market Share by Region (2021-2026) Table 21. Global Hepatitis C Drug Sales Market Share by Region (2027-2032) Table 22. Global Hepatitis C Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Hepatitis C Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Hepatitis C Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Hepatitis C Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Hepatitis C Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Hepatitis C Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Hepatitis C Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Hepatitis C Drug Manufacturers, Product Type & Application Table 30. Global Hepatitis C Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Hepatitis C Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Hepatitis C Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Hepatitis C Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Hepatitis C Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Hepatitis C Drug Revenue Market Share by Type (2021-2026) Table 37. Global Hepatitis C Drug Revenue Market Share by Type (2027-2032) Table 38. Global Hepatitis C Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Hepatitis C Drug Sales by Type (2021-2026) & (K Units) Table 40. Global Hepatitis C Drug Sales by Type (2027-2032) & (K Units) Table 41. Global Hepatitis C Drug Sales Market Share by Type (2021-2026) Table 42. Global Hepatitis C Drug Sales Market Share by Type (2027-2032) Table 43. Global Hepatitis C Drug Price by Type (2021-2026) & (US$/Unit) Table 44. Global Hepatitis C Drug Price by Type (2027-2032) & (US$/Unit) Table 45. Global Hepatitis C Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Hepatitis C Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Hepatitis C Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Hepatitis C Drug Revenue Market Share by Application (2021-2026) Table 49. Global Hepatitis C Drug Revenue Market Share by Application (2027-2032) Table 50. Global Hepatitis C Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Hepatitis C Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Hepatitis C Drug Sales by Application (2027-2032) & (K Units) Table 53. Global Hepatitis C Drug Sales Market Share by Application (2021-2026) Table 54. Global Hepatitis C Drug Sales Market Share by Application (2027-2032) Table 55. Global Hepatitis C Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Hepatitis C Drug Price by Application (2027-2032) & (US$/Unit) Table 57. Johnson & Johnson Company Information Table 58. Johnson & Johnson Business Overview Table 59. Johnson & Johnson Hepatitis C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Johnson & Johnson Hepatitis C Drug Product Portfolio Table 61. Johnson & Johnson Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Hepatitis C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Merck Hepatitis C Drug Product Portfolio Table 66. Merck Recent Development Table 67. AbbVie Company Information Table 68. AbbVie Business Overview Table 69. AbbVie Hepatitis C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. AbbVie Hepatitis C Drug Product Portfolio Table 71. AbbVie Recent Development Table 72. Kenilworth Company Information Table 73. Kenilworth Business Overview Table 74. Kenilworth Hepatitis C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Kenilworth Hepatitis C Drug Product Portfolio Table 76. Kenilworth Recent Development Table 77. Gilead Company Information Table 78. Gilead Business Overview Table 79. Gilead Hepatitis C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Gilead Hepatitis C Drug Product Portfolio Table 81. Gilead Recent Development Table 82. Bristol-Myers Squibb Company Information Table 83. Bristol-Myers Squibb Business Overview Table 84. Bristol-Myers Squibb Hepatitis C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Bristol-Myers Squibb Hepatitis C Drug Product Portfolio Table 86. Bristol-Myers Squibb Recent Development Table 87. North America Hepatitis C Drug Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Hepatitis C Drug Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Hepatitis C Drug Sales by Type (2021-2026) & (K Units) Table 90. North America Hepatitis C Drug Sales by Type (2027-2032) & (K Units) Table 91. North America Hepatitis C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Hepatitis C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Hepatitis C Drug Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Hepatitis C Drug Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Hepatitis C Drug Sales by Application (2021-2026) & (K Units) Table 96. North America Hepatitis C Drug Sales by Application (2027-2032) & (K Units) Table 97. North America Hepatitis C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Hepatitis C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Hepatitis C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Hepatitis C Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Hepatitis C Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Hepatitis C Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Hepatitis C Drug Sales by Country (2021-2026) & (K Units) Table 104. North America Hepatitis C Drug Sales by Country (2027-2032) & (K Units) Table 105. North America Hepatitis C Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Hepatitis C Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 108. Canada Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 109. Europe Hepatitis C Drug Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Hepatitis C Drug Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Hepatitis C Drug Sales by Type (2021-2026) & (K Units) Table 112. Europe Hepatitis C Drug Sales by Type (2027-2032) & (K Units) Table 113. Europe Hepatitis C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Hepatitis C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Hepatitis C Drug Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Hepatitis C Drug Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Hepatitis C Drug Sales by Application (2021-2026) & (K Units) Table 118. Europe Hepatitis C Drug Sales by Application (2027-2032) & (K Units) Table 119. Europe Hepatitis C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Hepatitis C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Hepatitis C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Hepatitis C Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Hepatitis C Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Hepatitis C Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Hepatitis C Drug Sales by Country (2021-2026) & (K Units) Table 126. Europe Hepatitis C Drug Sales by Country (2027-2032) & (K Units) Table 127. Europe Hepatitis C Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Hepatitis C Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 130. France Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 131. U.K. Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 132. Italy Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 134. China Hepatitis C Drug Revenue by Type (2021-2026) & (US$ Million) Table 135. China Hepatitis C Drug Revenue by Type (2027-2032) & (US$ Million) Table 136. China Hepatitis C Drug Sales by Type (2021-2026) & (K Units) Table 137. China Hepatitis C Drug Sales by Type (2027-2032) & (K Units) Table 138. China Hepatitis C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Hepatitis C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Hepatitis C Drug Revenue by Application (2021-2026) & (US$ Million) Table 141. China Hepatitis C Drug Revenue by Application (2027-2032) & (US$ Million) Table 142. China Hepatitis C Drug Sales by Application (2021-2026) & (K Units) Table 143. China Hepatitis C Drug Sales by Application (2027-2032) & (K Units) Table 144. China Hepatitis C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Hepatitis C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Hepatitis C Drug Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Hepatitis C Drug Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Hepatitis C Drug Sales by Type (2021-2026) & (K Units) Table 149. Asia Hepatitis C Drug Sales by Type (2027-2032) & (K Units) Table 150. Asia Hepatitis C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Hepatitis C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Hepatitis C Drug Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Hepatitis C Drug Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Hepatitis C Drug Sales by Application (2021-2026) & (K Units) Table 155. Asia Hepatitis C Drug Sales by Application (2027-2032) & (K Units) Table 156. Asia Hepatitis C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Hepatitis C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Hepatitis C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Hepatitis C Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Hepatitis C Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Hepatitis C Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Hepatitis C Drug Sales by Country (2021-2026) & (K Units) Table 163. Asia Hepatitis C Drug Sales by Country (2027-2032) & (K Units) Table 164. Asia Hepatitis C Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Hepatitis C Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 167. South Korea Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 168. India Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 169. Australia Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Hepatitis C Drug Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Hepatitis C Drug Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Hepatitis C Drug Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Hepatitis C Drug Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Hepatitis C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Hepatitis C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Hepatitis C Drug Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Hepatitis C Drug Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Hepatitis C Drug Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Hepatitis C Drug Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Hepatitis C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Hepatitis C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Hepatitis C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Hepatitis C Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Hepatitis C Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Hepatitis C Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Hepatitis C Drug Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Hepatitis C Drug Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Hepatitis C Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Hepatitis C Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 193. Argentina Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 194. Chile Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 195. Colombia Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 196. Peru Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 198. Israel Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 199. UAE Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 200. Turkey Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 201. Iran Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 202. Egypt Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Hepatitis C Drug Distributors List Table 206. Hepatitis C Drug Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Hepatitis C Drug Image Figure 2. Global Hepatitis C Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis C Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rx Image Figure 5. OTC Image Figure 6. Global Hepatitis C Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hepatitis C Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Hepatitis C Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Hepatitis C Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Hepatitis C Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Hepatitis C Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Hepatitis C Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Hepatitis C Drug Sales (2021-2032) & (K Units) Figure 17. Global Hepatitis C Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Hepatitis C Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Hepatitis C Drug Sales YoY (2021-2032) & (K Units) Figure 20. Europe Hepatitis C Drug Sales YoY (2021-2032) & (K Units) Figure 21. China Hepatitis C Drug Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Hepatitis C Drug Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Hepatitis C Drug Sales YoY (2021-2032) & (K Units) Figure 24. Global Hepatitis C Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Hepatitis C Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Hepatitis C Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Hepatitis C Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Hepatitis C Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Hepatitis C Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Hepatitis C Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Hepatitis C Drug Sales Market Share by Type (2021-2032) Figure 33. Global Hepatitis C Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Hepatitis C Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Hepatitis C Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Hepatitis C Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Hepatitis C Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Hepatitis C Drug Sales Market Share by Application (2021-2032) Figure 39. North America Hepatitis C Drug Revenue Share by Type (2021-2032) Figure 40. North America Hepatitis C Drug Sales Share by Type (2021-2032) Figure 41. North America Hepatitis C Drug Revenue Share by Application (2021-2032) Figure 42. North America Hepatitis C Drug Sales Share by Application (2021-2032) Figure 43. North America Hepatitis C Drug Revenue Share by Country (2021-2032) Figure 44. North America Hepatitis C Drug Sales Share by Country (2021-2032) Figure 45. Europe Hepatitis C Drug Revenue Share by Type (2021-2032) Figure 46. Europe Hepatitis C Drug Sales Share by Type (2021-2032) Figure 47. Europe Hepatitis C Drug Revenue Share by Application (2021-2032) Figure 48. Europe Hepatitis C Drug Sales Share by Application (2021-2032) Figure 49. Europe Hepatitis C Drug Revenue Share by Country (2021-2032) Figure 50. Europe Hepatitis C Drug Sales Share by Country (2021-2032) Figure 51. China Hepatitis C Drug Revenue Share by Type (2021-2032) Figure 52. China Hepatitis C Drug Sales Share by Type (2021-2032) Figure 53. China Hepatitis C Drug Revenue Share by Application (2021-2032) Figure 54. China Hepatitis C Drug Sales Share by Application (2021-2032) Figure 55. Asia Hepatitis C Drug Revenue Share by Type (2021-2032) Figure 56. Asia Hepatitis C Drug Sales Share by Type (2021-2032) Figure 57. Asia Hepatitis C Drug Revenue Share by Application (2021-2032) Figure 58. Asia Hepatitis C Drug Sales Share by Application (2021-2032) Figure 59. Asia Hepatitis C Drug Revenue Share by Country (2021-2032) Figure 60. Asia Hepatitis C Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Hepatitis C Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Hepatitis C Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Hepatitis C Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Hepatitis C Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Hepatitis C Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Hepatitis C Drug Sales Share by Country (2021-2032) Figure 67. Hepatitis C Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Hepatitis C Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rx
  • OTC
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Johnson & Johnson
  • Merck
  • AbbVie
  • Kenilworth
  • Gilead
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hepatitis C Drug Market by Type
  3. 1.2.1 Global Hepatitis C Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rx
  5. 1.2.3 OTC
  6. 1.3 Hepatitis C Drug Market by Application
  7. 1.3.1 Global Hepatitis C Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Hepatitis C Drug Market Dynamics
  1. 2.1 Hepatitis C Drug Industry Trends
  2. 2.2 Hepatitis C Drug Industry Drivers
  3. 2.3 Hepatitis C Drug Industry Opportunities and Challenges
  4. 2.4 Hepatitis C Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hepatitis C Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hepatitis C Drug Revenue by Region
  3. 3.2.1 Global Hepatitis C Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hepatitis C Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Hepatitis C Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Hepatitis C Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hepatitis C Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hepatitis C Drug Sales by Region
  9. 3.4.1 Global Hepatitis C Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hepatitis C Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Hepatitis C Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Hepatitis C Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hepatitis C Drug Revenue by Manufacturers
  2. 4.1.1 Global Hepatitis C Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hepatitis C Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hepatitis C Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hepatitis C Drug Sales by Manufacturers
  6. 4.2.1 Global Hepatitis C Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hepatitis C Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hepatitis C Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hepatitis C Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hepatitis C Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hepatitis C Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hepatitis C Drug Manufacturers, Product Type & Application
  13. 4.7 Global Hepatitis C Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hepatitis C Drug Market CR5 and HHI
  16. 4.8.2 2025 Hepatitis C Drug Tier 1, Tier 2, and Tier 3
5 Hepatitis C Drug Market by Type
  1. 5.1 Global Hepatitis C Drug Revenue by Type
  2. 5.1.1 Global Hepatitis C Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hepatitis C Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hepatitis C Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hepatitis C Drug Sales by Type
  6. 5.2.1 Global Hepatitis C Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hepatitis C Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Hepatitis C Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hepatitis C Drug Price by Type
6 Hepatitis C Drug Market by Application
  1. 6.1 Global Hepatitis C Drug Revenue by Application
  2. 6.1.1 Global Hepatitis C Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hepatitis C Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hepatitis C Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hepatitis C Drug Sales by Application
  6. 6.2.1 Global Hepatitis C Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hepatitis C Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Hepatitis C Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hepatitis C Drug Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Hepatitis C Drug Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Hepatitis C Drug Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 AbbVie
  14. 7.3.1 AbbVie Company Information
  15. 7.3.2 AbbVie Business Overview
  16. 7.3.3 AbbVie Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AbbVie Hepatitis C Drug Product Portfolio
  18. 7.3.5 AbbVie Recent Developments
  19. 7.4 Kenilworth
  20. 7.4.1 Kenilworth Company Information
  21. 7.4.2 Kenilworth Business Overview
  22. 7.4.3 Kenilworth Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Kenilworth Hepatitis C Drug Product Portfolio
  24. 7.4.5 Kenilworth Recent Developments
  25. 7.5 Gilead
  26. 7.5.1 Gilead Company Information
  27. 7.5.2 Gilead Business Overview
  28. 7.5.3 Gilead Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Gilead Hepatitis C Drug Product Portfolio
  30. 7.5.5 Gilead Recent Developments
  31. 7.6 Bristol-Myers Squibb
  32. 7.6.1 Bristol-Myers Squibb Company Information
  33. 7.6.2 Bristol-Myers Squibb Business Overview
  34. 7.6.3 Bristol-Myers Squibb Hepatitis C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bristol-Myers Squibb Hepatitis C Drug Product Portfolio
  36. 7.6.5 Bristol-Myers Squibb Recent Developments
8 North America
  1. 8.1 North America Hepatitis C Drug Market Size by Type
  2. 8.1.1 North America Hepatitis C Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Hepatitis C Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Hepatitis C Drug Price by Type (2021-2032)
  5. 8.2 North America Hepatitis C Drug Market Size by Application
  6. 8.2.1 North America Hepatitis C Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Hepatitis C Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Hepatitis C Drug Price by Application (2021-2032)
  9. 8.3 North America Hepatitis C Drug Market Size by Country
  10. 8.3.1 North America Hepatitis C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hepatitis C Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hepatitis C Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Hepatitis C Drug Market Size by Type
  2. 9.1.1 Europe Hepatitis C Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hepatitis C Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Hepatitis C Drug Price by Type (2021-2032)
  5. 9.2 Europe Hepatitis C Drug Market Size by Application
  6. 9.2.1 Europe Hepatitis C Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hepatitis C Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Hepatitis C Drug Price by Application (2021-2032)
  9. 9.3 Europe Hepatitis C Drug Market Size by Country
  10. 9.3.1 Europe Hepatitis C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hepatitis C Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hepatitis C Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Hepatitis C Drug Market Size by Type
  2. 10.1.1 China Hepatitis C Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Hepatitis C Drug Sales by Type (2021-2032)
  4. 10.1.3 China Hepatitis C Drug Price by Type (2021-2032)
  5. 10.2 China Hepatitis C Drug Market Size by Application
  6. 10.2.1 China Hepatitis C Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Hepatitis C Drug Sales by Application (2021-2032)
  8. 10.2.3 China Hepatitis C Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hepatitis C Drug Market Size by Type
  2. 11.1.1 Asia Hepatitis C Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hepatitis C Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Hepatitis C Drug Price by Type (2021-2032)
  5. 11.2 Asia Hepatitis C Drug Market Size by Application
  6. 11.2.1 Asia Hepatitis C Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hepatitis C Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Hepatitis C Drug Price by Application (2021-2032)
  9. 11.3 Asia Hepatitis C Drug Market Size by Country
  10. 11.3.1 Asia Hepatitis C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hepatitis C Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hepatitis C Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hepatitis C Drug Market Size by Type
  2. 12.1.1 SAMEA Hepatitis C Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hepatitis C Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hepatitis C Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Hepatitis C Drug Market Size by Application
  6. 12.2.1 SAMEA Hepatitis C Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hepatitis C Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hepatitis C Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Hepatitis C Drug Market Size by Country
  10. 12.3.1 SAMEA Hepatitis C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hepatitis C Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hepatitis C Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hepatitis C Drug Value Chain Analysis
  2. 13.1.1 Hepatitis C Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hepatitis C Drug Production Mode & Process
  6. 13.2 Hepatitis C Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hepatitis C Drug Distributors
  9. 13.2.3 Hepatitis C Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst